Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 17/20 | 0.37 |
| ▸ | RARB | P10826 | 2/20 | 0.37 |
| ▸ | RARG | P13631 | 2/20 | 0.37 |
| ▸ | RXRB | P28702 | 14/20 | 0.36 |
| ▸ | RXRG | P48443 | 14/20 | 0.36 |
| ▸ | RARA | P10276 | 2/20 | 0.33 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.32 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23442476 | 0.91 | RXRA (0.34) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL23445690 | 0.88 | RXRA (0.33) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL23445001 | 0.88 | RXRA (0.30) | RXRARXRBRXRG | |
| SCHEMBL22949325 | 0.87 | RXRA (0.34) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL23446797 | 0.85 | RXRA (0.32) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL22934084 | 0.83 | RXRA (0.39) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL23442772 | 0.83 | RXRA (0.39) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL23446299 | 0.83 | RXRA (0.34) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL23438804 | 0.81 | RXRA (0.39) | RXRARARBRARGRXRBRXRG | |
| SCHEMBL22949046 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11685751-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11685751-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20230061019-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2023-03-02 | — | — | US | disclosed |
| EP-3919500-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-12-08 | — | — | EP | disclosed |
| WO-2021107681-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
| WO-2021107680-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
| WO-2021107694-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230061019-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, LEF1 | RXRA 1028/4885RARB 874/4885RARG 738/4885 |
| US-11780856-B2 | Compound and organic light-emitting device comprising same | CRY1, CRY2, LEF1 | RXRA 2187/4885RARB 1767/4885RARG 1720/4885 |
| US-11685751-B2 | Compound and organic light-emitting element comprising same | CRY1, CRY2, LEF1 | RXRA 1028/4885RARB 874/4885RARG 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.